Developmental Research Program
The Developmental Research Program within the Mayo Clinic Ovarian Cancer SPORE supports innovative, scientifically sound research projects from which findings can be translated into clinically relevant interventions that will reduce the burden of ovarian cancer.
The Developmental Research Program:
- Fosters innovative laboratory, population and clinical study proposals that have strong translational potential
- Encourages and supports interdisciplinary collaboration in translational research in ovarian cancer
- Generates new hypotheses that can be tested in larger scale research projects or in clinical trials of ovarian cancer
The Developmental Research Program provides a minimum of $200,000 to support at least four meritorious projects annually ($100,000 from the SPORE and a $100,000 match from Mayo Clinic). A second year of funding might be possible, depending on a project's progress.
The Developmental Research Program uses a defined process to call for applications and review submissions with the expertise of the Ovarian Cancer SPORE's Internal Scientific Advisory Committee and other experienced investigators as needed.
Criteria for selection of research projects for funding include:
- The likelihood that the work will impact major challenges in ovarian cancer
- Scientific merit
- Translational potential
- Qualifications of the key personnel
Pilot projects supported through this program are expected to generate new hypotheses that can be addressed in existing SPORE-sponsored projects or through peer-reviewed external grant support.
The director of the Developmental Research Program is: